Hepatitis C Community
Drug Approved for Low Platelet Patients
About This Community:

This forum is for questions about medical issues and research aspects of Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new Hepatitis Social/Living with Hepatitis forum

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

Drug Approved for Low Platelet Patients

http://health.yahoo.net/news/s/nm/fda-approves-glaxo-ligand-platelet-drug-for-hepatitis-c-patients

Good news for someone like myself.
Tags: platelets
3 Comments Post a Comment
Blank
1280753_tn?1367761532
i guess that's good news, but my liver doc said that there are some dangerous sides with it, and he suggested i not take it. at the time i asked him about it, the FDA had not approved it for HCV. thanks for the info.
Blank
446474_tn?1404424777
Promacta  (eltrombopag) has been available since 2008 for ITP and has used off label by some doctors to treat thrombocytopenia in treating low platelet counts in in hepatitis C patients doing interferon based treatment. The FDA has expanded its use now to include treating hepatitis C patients.
NOTE: Safety and efficacy have not been established in combination with direct-acting antiviral agents approved for treatment of chronic hepatitis C genotype 1 infection.

It is usually only more advanced cirrhotics with low platelet counts before starting treatment that ever need to prevent platelet counts from getting dangerously low if they treat with peg-INF. I know the Gilead's Sofobuvir taken with Ribavirin does not have this effect. And I can't see other non-peg-INF treatments from causing thrombocytopenia.

Promacta is only a temporary solution to raise platelet counts and may be used along with platelet transfusions.

Also in cirrhotics there is risk involved as Promacta can be toxic to the liver  and can cause decompensation

"BOXED WARNING

Promacta may cause hepatotoxicity. Promacta, in combination with interferon and ribavirin in patients with chronic hepatitis C, may increase the risk of hepatic decompensation. Patients receiving therapy with Promacta must have regular monitoring of serum liver tests. Discontinue Promacta if ALT levels increase to >/=3X upper limit of normal (ULN) in patients with normal liver function or >/= 3X baseline in patients with pre-treatment elevations in transaminases and are: progressive; or persistent for >/=4 weeks; or accompanied by increased direct bilirubin; or accompanied by clinical symptoms of liver injury or evidence of hepatic decompensation. Reinitiating treatment with Promacta is not recommended and should be considered only with close medical supervision and under exceptional circumstances where the potential benefit outweighs the risk."

Crossroadsec used at her transplant center.

Cheers!
Hector
Blank
4043517_tn?1374010173
advised by med help to respond, shot down again on any post I make regarding new treatment options, so great medhelp, I responded.
Blank
Post a Comment
To
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis C Community Resources
RSS Expert Activity
469720_tn?1388149949
Blank
Abdominal Aortic Aneurysm-treatable... Blank
Oct 04 by Lee Kirksey, MDBlank
242532_tn?1269553979
Blank
The 3 Essentials to Ending Emotiona...
Sep 18 by Roger Gould, M.D.Blank
242532_tn?1269553979
Blank
Control Emotional Eating with this ...
Sep 04 by Roger Gould, M.D.Blank
Top Hepatitis Answerers
1815939_tn?1377995399
Blank
pooh55811
446474_tn?1404424777
Blank
HectorSF
CA
179856_tn?1333550962
Blank
nygirl7
Planet Earth, CT
Avatar_f_tn
Blank
Livelife777
Avatar_m_tn
Blank
can-do-man
IN
766573_tn?1365170066
Blank
Idyllic